Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Chinese Patent Office
Cipla
Daiichi Sankyo
Citi

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 8,748,475

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,748,475
Title:Methods and compositions for treating lupus
Abstract: The invention relates to compositions and methods for treating lupus. The methods typically comprise the step of administrating one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA in an amount sufficient to treat the lupus; preferably by modulating cytokine expression. Preferably the compound is in an amount less than sufficient to substantially inhibit cyclin dependent kinases.
Inventor(s): Wang; Longgui (Flushing, NY), Mencher; Simon K. (New York, NY)
Assignee: Natrogen Therapeutics International, Inc. (New York, NY)
Application Number:13/197,164
Patent Claims:see list of patent claims

Details for Patent 8,748,475

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 002 2011-03-09 ➤ Sign Up Natrogen Therapeutics International, Inc. (New York, NY) ➤ Sign Up RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Sign Up Natrogen Therapeutics International, Inc. (New York, NY) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,748,475

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 03051900 Jun 26, 2003
World Intellectual Property Organization (WIPO) 2005069933 Aug 04, 2005
World Intellectual Property Organization (WIPO) 2005069933 Sep 09, 2005
United States of America 2004225002 Nov 11, 2004
United States of America 2005154046 Jul 14, 2005
United States of America 2005197381 Sep 08, 2005
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Mallinckrodt
Teva
Baxter
Covington
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.